Paediatric anaesthesia & critical care

High-flow nasal oxygen for children's airway surgery to reduce hypoxaemic events: a randomised controlled trial

Lancet Respir MedPublished Randomised controlled trial

Authors' conclusion

Nasal high-flow oxygen during tubeless upper airway surgery did not reduce the proportion of interruptions of the procedures for rescue oxygenation compared with standard care.

Study context

Population
Children aged 0–16 years requiring tubeless upper airway surgery, 5 tertiary hospitals in Australiaprocedures in 483 children (ITT)
Participants
528 children
Comparison
Nasal high-flow oxygen vs standard oxygen therapy
  • High-flow oxygenn = 267
  • Standard caren = 261reference
Primary endpoint
Successful anaesthesia without interruption of surgery for rescue oxygenation (positive pressure ventilation by bag mask, ETT or LMA)
Methodological detailsmulticentre, open-label (oxygen therapy not masked; investigators blinded until data lock), stratified by site and age
  • Multicentre
  • Open-label (oxygen therapy not masked; investigators blinded until data lock)
  • Stratified by site and age

Primary result

As reported in the abstract

Successful anaesthesia without interruption of surgery for rescue oxygenation (higher = better)

Secondary outcomes

OutcomeHigh-flow oxygenStandard careRR (95% CI)
Procedures with a hypoxaemic event (SpO2 <90%)19%22%0.86 (0.58–1.24)

Other prespecified secondary outcomes

None showed a significant difference between groups

Safety

Adverse events (epistaxis, laryngospasm, bronchospasm, hypoxaemia, bradycardia, cardiac arrest, hypotension, death)

Similar in both study groups

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

High-flow nasal oxygen for children's airway surgery to reduce hypoxaemic events: a randomised controlled trial. Lancet Respir Med. Published 21 May 2024. doi:10.1016/s2213-2600(24)00115-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.